Lista de obras - Miguel-Angel Perales - Dominio Público Uruguay

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A compilation of fecal microbiome shotgun metagenomics from hematopoietic cell transplantation patients

publication published on 18 May 2022

A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients

artículo científico publicado en 2013

A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies

artículo científico publicado en 2014

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2018

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality

artículo científico publicado en 2013

CD4 help and tumor immunity: beyond the activation of cytotoxic T lymphocytes

artículo científico publicado en 2004

CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems

artículo científico publicado en 2004

Challenges and potential solutions for recruitment and retention of hematopoietic cell transplantation physicians: the National Marrow Donor Program's System Capacity Initiative Physician Workforce Group report.

artículo científico

Checkpoint inhibitors in AML: are we there yet?

scientific article published on 06 December 2019

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation

artículo científico publicado en 2018

Clinical applications of palifermin: amelioration of oral mucositis and other potential indications

artículo científico publicado en 2013

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Tran

scientific article published on 15 May 2019

Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients

publication published on 02 March 2021

Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee.

artículo científico publicado en 2014

Cytokine-FC fusion genes as molecular adjuvants for DNA vaccines.

artículo científico publicado en 2010

Effect of interleukin 12 on in vitro HIV type 1 replication depends on clinical stage.

artículo científico publicado en 1996

Enhanced responses to tumor immunization following total body irradiation are time-dependent

artículo científico publicado en 2013

Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study

artículo científico publicado en 2021

Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin

artículo científico publicado en 2014

GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: implications for DNA vaccines

scientific article published on 01 January 2002

Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines.

artículo científico publicado en 2004

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

artículo científico publicado en 2022

Haematopoietic cell transplantation outcomes are linked to intestinal mycobiota dynamics and an expansion of Candida parapsilosis complex species

artículo científico publicado en 2021

Immune recovery after allogeneic hematopoietic stem cell transplantation: is it time to revisit how patients are monitored?

artículo científico publicado en 2012

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

artículo científico publicado en 2020

Intravenous Busulfan and Melphalan, Tacrolimus, and Short-Course Methotrexate Followed by Unmodified HLA-Matched Related or Unrelated Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Hematologic Malignancies

artículo científico publicado en 2007

Lactose drives Enterococcus expansion to promote graft-versus-host disease

scientific article published on 01 November 2019

Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant ⬇️

artículo científico publicado el 31 de enero de 2012

Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome

artículo científico publicado en 2014

MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT

artículo científico publicado en 2022

Melanoma vaccines

artículo científico publicado en 2002

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

artículo científico publicado en 2020

Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.

artículo científico publicado en 2011

Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation

artículo científico

Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies

artículo científico publicado en 2021

Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.

artículo científico publicado en 2008

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

scientific article published on 28 June 2019

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

artículo científico publicado en 2015

Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo

artículo científico publicado en 2002

Regarding "Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study"

scientific article published on 27 May 2019

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

artículo científico publicado en 2019

Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin

artículo científico publicado en 2011

T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease

artículo científico publicado en 2012

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

artículo científico publicado en 2015

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

artículo científico publicado en 2015

The gut microbiota is associated with immune cell dynamics in humans

artículo científico publicado en 2020

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

artículo científico publicado en 2013

Lista de obras de Miguel-Angel Perales

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

A compilation of fecal microbiome shotgun metagenomics from hematopoietic cell transplantation patients

A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients

A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality

CD4 help and tumor immunity: beyond the activation of cytotoxic T lymphocytes

CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems

Challenges and potential solutions for recruitment and retention of hematopoietic cell transplantation physicians: the National Marrow Donor Program's System Capacity Initiative Physician Workforce Group report.

Checkpoint inhibitors in AML: are we there yet?

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation

Clinical applications of palifermin: amelioration of oral mucositis and other potential indications

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Tran

Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients

Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee.

Cytokine-FC fusion genes as molecular adjuvants for DNA vaccines.

Effect of interleukin 12 on in vitro HIV type 1 replication depends on clinical stage.

Enhanced responses to tumor immunization following total body irradiation are time-dependent

Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study

Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin

GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: implications for DNA vaccines

Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines.

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Haematopoietic cell transplantation outcomes are linked to intestinal mycobiota dynamics and an expansion of Candida parapsilosis complex species

Immune recovery after allogeneic hematopoietic stem cell transplantation: is it time to revisit how patients are monitored?

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

Intravenous Busulfan and Melphalan, Tacrolimus, and Short-Course Methotrexate Followed by Unmodified HLA-Matched Related or Unrelated Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Hematologic Malignancies

Lactose drives Enterococcus expansion to promote graft-versus-host disease

Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant ⬇️

Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome

MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT

Melanoma vaccines

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.

Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation

Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies

Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo

Regarding "Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study"

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin

T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

The gut microbiota is associated with immune cell dynamics in humans

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?